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pplicability and Clinical Relevance of
he Transfer Function Method in the Assessment
f Baroreflex Sensitivity in Heart Failure Patients
ian Domenico Pinna, MS, Roberto Maestri, MS, Soccorso Capomolla, MD, Oreste Febo, MD,
lena Robbi, BS, Franco Cobelli, MD, Maria Teresa La Rovere, MD
ontescano, Italy
OBJECTIVES We sought to assess applicability, clinical correlates, and prognostic value of the transfer
function method for measuring baroreflex sensitivity (TF-BRS).
BACKGROUND Abnormalities in autonomic reflexes play an important role in the development and
progression of chronic heart failure (CHF). Simple and non-invasive techniques for clinical
measurement of such reflexes are desirable.
METHODS In 317 stable CHF patients in sinus rhythm (median age [interquartile range]: 54 years [48
to 59 years], New York Heart Association [NYHA] functional class II to III: 88%, left
ventricular ejection fraction [LVEF]: 27% [22% to 33%]) we recorded electrocardiograms and
non-invasive arterial pressure during paced breathing to measure TF-BRS.
RESULTS Owing to a high number of ectopic beats, TF-BRS could be computed in 72% of the patients;
TF-BRS was lower in NYHA functional class III to IV and mitral regurgitation 2 to 3 (p 
0.0005 for both). Correlation with LVEF and standard deviation of all normal-to-normal
intervals was 0.18 and 0.31 (p  0.001 for both). During a mean follow-up of 26 months,
23% of the patients experienced a cardiac event. A depressed TF-BRS (3.1 ms/mmHg) was
significantly associated with the outcome (hazard ratio 3.2, 95% confidence interval [CI] 1.7
to 6.0, p  0.0003). Patients with a missing TF-BRS had a high event rate (36%).
Combining this information with available TF-BRS measurements, a new prognostic index
could be computed in 97% of the patients that significantly predicted the outcome after
adjustment for clinical and functional variables (hazard ratio 2.5, 95% CI 1.3 to 4.6 p 
0.004).
CONCLUSIONS In CHF patients in sinus rhythm, TF-BRS conveys relevant clinical and prognostic
information, but its measurability is markedly affected by ectopic activity. Nevertheless, a
TF-BRS–based risk index carrying significant and independent prognostic information can
be computed in almost all patients. (J Am Coll Cardiol 2005;46:1314–21) © 2005 by the
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.06.062American College of Cardiology Foundation
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ueurohormonal activation is a key factor in the develop-
ent and progression of chronic heart failure (CHF) (1,2).
lthough the mechanisms accounting for this excitatory
tate have not been fully elucidated yet, it has long been
ypothesized that abnormalities in arterial and cardiopul-
onary reflexes play an important pathogenic role by
educing the restraining influence on the sympathetic ner-
ous system and the excitatory influence on the vagal
utflow to the heart (3–5). Therefore, the assessment of
aroreceptor reflex function has been included within the set
f relevant methods to investigate the pathophysiology of
bnormal autonomic regulation in patients with heart fail-
re (6–9).
Besides its relevance in basic research, measuring the
aroreflex has also been shown to be a source of valuable
nformation in the clinical management of CHF patients,
articularly in prognostic evaluation and assessment of
From the Department of Cardiology and Biomedical Engineering, Salvatore
augeri Foundation, IRCCS, Scientific Institute of Montescano, Montescano (PV),
taly.p
Manuscript received December 13, 2004; revised manuscript received June 16,
005, accepted June 21, 2005.reatment effect (10–12), and many efforts have been
evoted to the development of non-invasive methods that
o not require the use of vasoactive drugs (13–15). These
echniques, based on the analysis of spontaneous oscillations
f arterial pressure and RR interval, are very attractive in
erms of simplicity, patient acceptability, and cost.
We have focused our attention on the transfer function
TF) method for measuring the baroreceptor-heart rate
eflex sensitivity (TF-BRS) (16), on the ground of its sound
athematical foundations and because it allows a clear
efinition of the oscillatory components that contribute to
RS measurement. Major methodological issues related to
he practical use of this technique, particularly in situations
f a markedly depressed reflex and/or poor signal-to-noise
atio, have recently been investigated (17), and new appli-
ation criteria developed (18,19).
The present investigation was undertaken to assess the
pplicability and clinical relevance of the TF-BRS method
n the setting of moderate-to-severe CHF patients. Partic-
larly, we aimed at determining: 1) the actual proportion of
atients in whom the measurement can be performed (i.e.,
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October 4, 2005:1314–21 Applicability of the Transfer Function Methodhe measurability of TF-BRS); 2) its relationship with
linical and functional indicators of heart failure; and 3) its
rognostic value. We believe that addressing these points is
rucial to determine whether the TF-BRS method can be
onsidered a potential candidate for pathophysiological
nvestigations and clinical applications.
ETHODS
tudy patients. From January 1996 to August 2002, 633
onsecutive patients with dilated cardiomyopathy and
oderate-to-severe heart failure, were referred to the Heart
ailure Unit of the Institute of Montescano for evaluation
nd treatment of heart failure, including evaluation for heart
ransplantation. One hundred sixty-two patients were ex-
luded because of atrial fibrillation, atrial flutter, or pace-
aker implantation, which did not allow analysis of cardio-
ascular variability. Of the remaining 471 in sinus rhythm,
22 were excluded mainly because they were clinically
nstable or had had a recent (within six months) myocardial
nfarction or cardiac surgery. A further 32 patients were
xcluded owing to incomplete examinations, which did not
llow performance of multivariable statistical analysis. This
ed to a final sample of 317 cases available for the study. All
atients gave written informed consent and the study was
pproved by the local ethics committee.
xperimental protocol. Subjects were studied in the
orning, in the supine position. The experimental protocol
as carried out in our laboratory for autonomic evaluations
nd comprised: 1) instrumentation, patient’s familiarization
ith paced breathing (see the following text), and signal
tabilization (about 20 min); 2) 8-min recording of an
lectrocardiogram, lung volume (Respitrace Plus, Non-
nvasive Monitoring Systems, Miami Beach, Florida), and
on-invasive arterial blood pressure (Finapres 2300, Ohm-
da, Louisville, Kentucky) during spontaneous breathing;
nd 3) 8-min recording of the same signals during paced
reathing at 15 breaths/min (0.25 Hz).
To perform paced breathing, subjects were asked to
ollow a played-back human voice recording indicating
nspiratory and expiratory phases. To improve subjects’
Abbreviations and Acronyms
AUC  area under the curve
BRS  baroreceptor-heart rate reflex sensitivity
CHF  chronic heart failure
ICD  implantable cardioverter-defibrillator
LF  low frequency
LVEF  left ventricular ejection fraction
NYHA  New York Heart Association
ROC  receiver-operating characteristic
SAP  systolic arterial pressure
SDNN  standard deviation of all normal-to-normal
intervals
TF  transfer functionomfort, the breathing frequency was increased or decreased Mpon request within10% of the preset value (i.e., between
3.5 and 16.5 breaths/min).
ignal preprocessing. The electrocardiographic signal was
anually edited to correct for wrong QRS detections and
lassify ectopic beats. The RR interval (resolution 1 ms) and
ystolic arterial pressure (SAP) time series were then auto-
atically calculated.
omputation of TF-BRS. The TF-BRS was computed
n paced breathing recordings. The reasons for this choice
re two-fold. First, the TF method requires the SAP and
R oscillations in the low frequency (LF) band (0.04 to
.15 Hz) to be of non-respiratory origin (20,21); therefore,
eeping the breathing frequency out of this band is needed
22). Second, abnormal breathing patterns are common in
atients with CHF and exert a confounding effect on
ardiovascular variability measurements (23,24). Paced
reathing is effective in removing these patterns (23) and
oes not alter TF-BRS (25).
All signals (including lung volume) were plotted together
n the PC screen and the widest sub-record free from
rtifacts, large transients, or marked changes in the fluctu-
tion pattern of the signals interactively selected (26,27).
ecordings shorter than 3 min were excluded from subse-
uent analysis as the reliability of TF estimates would
ecome intolerably low (17).
Isolated ectopic beats were corrected (linear interpola-
ion), provided that: 1) their inclusion allowed a significant
ncrease of the analysis window; 2) they were preceded or
ollowed by at least 3 minutes of ectopy-free recording; and
) inclusion of the corrected beat did not change BRS by
ore than 15% (a threshold obtained by computer simula-
ions). The rationale for this procedure is that ectopic beats
Fig. 1A), as well as the corrections performed on them
Fig. 1B), might heavily affect TF-BRS measurements.
The transfer function between SAP and RR interval time
eries was obtained from bivariate spectral analysis (weighted
ovariance method, 0.03 Hz-bandwidth Parzen window)
17). For each frequency, the modulus of this function, or
ain, tells us how the amplitude of a sinusoidal SAP wave is
ransformed into the amplitude of the corresponding RR
nterval and is expressed in milliseconds per millimeters of
ercury (ms/mm Hg). The TF-BRS was finally computed
y averaging the gain function across the LF band (19).
linical evaluation, laboratory testing, and follow-up. Within
ne week from autonomic evaluation, standard clinical and
aboratory examinations, including two-dimensional echo-
ardiography, cardiopulmonary exercise testing, 24-h
olter recording, and routine blood test were performed.
ll measurements were entered into a dedicated database.
Time-event information during the follow-up was ob-
ained through periodic controls in the hospital, chart
eview, or telephone interview of patients, relatives, or
eferring physician.
tatistical analysis. The association between TF-BRS and
ategorical variables (e.g., etiology) was assessed by the
ann-Whitney U test, whereas the association with con-
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Applicability of the Transfer Function Method October 4, 2005:1314–21inuous variables (e.g., left ventricular ejection fraction
LVEF]) was assessed by linear correlation analysis. A p 
.05 was considered statistically significant and all tests were
wo-sided.
End point of survival analysis was total cardiac death,
ncluding appropriate and documented implantable
ardioverter-defibrillator (ICD) discharge for fast ventricu-
ar tachycardia, or ventricular fibrillation and urgent trans-
lantation (i.e., transplantation carried out upon patients
equiring ventricular support or in-hospital intensive care).
atients who underwent elective heart transplantation as
ell as patients who died of non-cardiac causes were
ensored at the time of the event.
To assess the ability of TF-BRS to discriminate between
atients who did and did not experience the study outcome
t two years, we computed the AUC (i.e., the area under the
eceiver-operating characteristic [ROC] curve), after exclu-
ion of patients with censored follow-up at 2 years. An
igure 1. Representative example of the dramatic effect that a single isolat
ensitivity by the transfer function method (TF-BRS). Tracings (A) show
remature complex at the beginning of the recording. Measurement of TF
rom the computation (i.e., starting the analysis window from the dashed
f the ectopic beat by linear interpolation. Despite the apparent negligible e
g, that is, 24% compared with the measurement obtained without the e
xample highlights the need to perform a careful check every time a correUC value of 0.5 indicates no predictive discrimination,hereas a value of 1 indicates perfect separation of patients
ith different outcomes. Two years was chosen because it
as close to the mean follow-up of the patients. The AUCs
ere compared by the Hanley-McNeil test.
The Kaplan-Meier method was used to estimate survival
urves and compute rates of survival (together with 95%
onfidence intervals [CIs]) at one, two, and three years.
urvival curves from different subgroups of patients were
ompared by the log-rank test.
The association between TF-BRS and survival was as-
essed by the Cox proportional hazards model, after dichot-
mization of the measurement according to the cut point
hat maximized the hazard ratio. To this purpose, we
alculated the hazard ratio for progressively increasing
F-BRS values comprised between the 20th and 50th
ercentiles (to have an adequate number of patients in each
ubgroup) and identified the point at which the hazard ratio
ttained its maximum.
topic beat and its correction might have in the measurement of baroreflex
lic arterial pressure (SAP) and RR interval time series with a ventricular
on these signals gives 1.2 ms/mm Hg, whereas excluding the ectopic beat
ives 6.2 ms/mm Hg. Tracings (B) show the same signals after correction
n the fluctuation pattern of the two signals, TF-BRS becomes 4.7 ms/mm
c beat. Although the effect of the correction is not always so dramatic, this
is made.ed ec
systo
-BRS
bar) g
ffect oBecause failure to have a measurable BRS was associated
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October 4, 2005:1314–21 Applicability of the Transfer Function Methodith an increased risk of event, this information was used as
urrogate prognostic information in place of TF-BRS.
ccordingly, a risk index (TF risk index) was obtained in all
atients, regardless of having a measurable BRS.
The predictive value of the TF risk index was assessed by
nivariable and multivariable Cox analysis. The latter was
arried out using all clinical and functional parameters with
t least a weak association with the outcome (p  0.15) as
djusting factors. Model-building was carried out by a
tepwise procedure, with p  0.25 for entering a variable
nto the model and p  0.15 to remain into the model. At
he end of the stepwise process, only variables with p 0.05
ere retained in the final multivariable model. The assump-
ion of proportional hazards was assessed by plotting
choenfeld residuals.
Owing to the marked skewness in the distribution of
ome variables (including TF-BRS), descriptive statistics
re given as median, lower, and upper quartile, unless
therwise stated. The rate of ectopic beats is expressed as
vents per hour both for long-term and short-term record-
ngs. All analyses were performed with the SAS/STAT
tatistical package, release 8.02 (SAS Institute Inc., Cary,
orth Carolina).
ESULTS
emographic and clinical characteristics of the study pa-
ients are given in Table 1.
easurability of TF-BRS. Of the 317 recordings carried
ut for the computation of TF-BRS, 81 (26%) could not be
nalyzed, owing to a high number of ectopic events (113 [75
o 234]/h). Most of the events were of the ventricular type
95 [58 to 200]/h). Correlation with Holter arrhythmia data
as moderate both for ventricular (r  0.48, p  0.0001)
nd supra-ventricular beats (r  0.44, p  0.0001). Six
ecordings were excluded due to artifacts or large signal
ransients, whereas another two were excluded due to
mproper execution of paced breathing. Isolated ectopic
eats were corrected in 45 recordings. Thus, the analysis of
F-BRS was carried out in 228 recordings, that is, 72% of
hose available for the study. The median duration of
nalyzed recordings was 287 s (range 180 to 491 s), with a
edian TF-BRS of 3.5 (1.7 to 6.6) ms/mm Hg. Mean
oherence across the LF band was 0.29 (0.19 to 0.41).
linical correlates of TF-BRS. As shown in Table 2,
F-BRS was slightly lower in patients with ischemic
ompared with idiopathic cardiomyopathy, but the differ-
nce did not reach statistical significance (p  0.17). A
ignificant decrease of BRS was found in patients with New
ork Heart Association (NYHA) functional class III to IV
nd in those with mitral regurgitation grade 2 to 3. We did
ot find any association between TF-BRS and non-
ustained ventricular tachycardia (p  0.44). Low values of
he correlation coefficient were found between TF-BRS and
oth LVEF (r  0.18) and standard deviation of all
ormal-to-normal intervals (SDNN) (r  0.31), yet the sssociation was highly statistically significant (p  0.009
nd p  0.0001 respectively).
rognostic value of TF-BRS. During a mean follow-up
f 26 months (minimum to maximum: 0.2 to 36 months),
3 (23%) of the 317 patients enrolled in the study experi-
nced a cardiac event, including 6 urgent transplantations
nd 8 appropriate ICD discharges.
In the dataset of 228 patients with a measurable TF-BRS
mean follow-up: 27 months [minimum to maximum: 1.2
o 36 months]; event rate: 19%), TF-BRS was significantly
ower in the patients with a poor outcome (2.2 [1.0 to 5.7]
s. 3.8 [1.9 to 6.6] ms/mm Hg, p  0.014), and the AUC
SE for a two-year outcome event was 0.68  0.06. The
UC for the continuous variables shown in Table 1 ranged
rom 0.54  0.06 for 24-h mean RR (p  0.025 vs.
F-BRS) to 0.66  0.05 for SAP (p  0.40 vs. TF-BRS).
graphical example is given in Figure 2, where we have
able 1. Demographic, Clinical, and Functional Characteristics
f the Study Sample (n  317)
Characteristic
ge (yrs) 54 ( 48–59)
ender (% male) 84
YHA functional class (%)
I 10
II 51
III 37
IV 2
ause of CHF (%)
Ischemic cardiomyopathy 48
Idiopathic cardiomyopathy 40
Other 12
esting systolic arterial pressure (mm Hg) 110 (100–125)
esting diastolic arterial pressure (mm Hg) 70 (70–80)
VEF (%) 27 (22–33)
VESD (mm) 59 (50–66)
VEDD (mm) 70 (63–77)
itral regurgitation 2 to 3 (%) 32
eak VO2 (ml/kg/min) 15 (12–18)
4-h mean RR interval (ms) 800 (722–897)
PCs (No./h) 16 (3–71)
SVT (%) 39
DNN (ms) 89 (63–118)
UN (mg/dl) 48 (39–57)
odium (mEq/l) 140 (138–142)
reatinine (mg/dl) 1.13 (0.99–1.31)
otassium (mEq/l) 4.4 (4.1–4.6)
ilirubin (mg/dl) 0.74 (0.53–1.01)
edical therapy (%)
ACE inhibitors 85
Diuretics 84
Nitrates 49
Beta-blockers 42
Amiodarone 22
ontinuous variables are expressed as median (lower quartile to upper quartile).
ACE  angiotensin-converting enzyme; BUN  blood urea nitrogen; CHF 
hronic heart failure; LVEF left ventricular ejection fraction; LVESD, LVEDD
eft ventricular end systolic and diastolic diameter; NSVT non-sustained ventricular
achycardia; NYHA  New York Heart Association; Peak VO2  oxygen uptake at
he maximum level of exercise; SDNN standard deviation of normal-to-normal RR
ntervals; VPCs/h  ventricular premature contractions.uperimposed the ROC curves of TF-BRS and LVEF; in
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Applicability of the Transfer Function Method October 4, 2005:1314–21he overall region of best trade-off between sensitivity and
alse positive rate (1-Specificity), TF-BRS shows a superior
redictive discrimination compared with LVEF.
The optimum cutoff value for dichotomizing TF-BRS
as 3.1 ms/mm Hg. Kaplan-Meier survival curves are
hown in Figure 3. Results from Cox analysis and standard
gures of predictive accuracy for a two-year outcome event
re given in the middle column of Table 3. Patients with
epressed BRS showed a 3.2 increased risk of experiencing
study outcome during the follow-up, compared with those
ith a more preserved BRS. We did not find any evidence
f an interaction effect between dichotomized TF-BRS and
eta-blocker treatment (p  0.30).
elationship between missing measurements and sur-
ival. In the 81 patients in whom TF-BRS could not be
easured because of a high number of ectopic beats, the
igure 2. Receiver-operating characteristic curves for the prediction of a
wo-year outcome according to baroreflex sensitivity by the transfer
unction method (TF-BRS) (solid line) and left ventricular ejection
raction (LVEF) (dotted line). The identity line indicates no predictive
able 2. Association Between TF-BRS and Major Clinical
ariables With Categorical Scale (n  228)
TF-BRS (ms/mm Hg)
tiology
Ischemic cardiomyopathy 3.3 (1.5–5.9)
Idiopathic cardiomyopathy 4.0 (2.0–7.1)
YHA functional class
I–II 4.3 (2.4–8.0)
III–IV 2.2 (1.1–4.2)*
itral regurgitation
0–1 4.1 (2.3–7.4)
2–3 2.2 (1.1–5.2)†
SVT
No 3.5 (1.8–6.6)
Yes 3.3 (1.6–6.1)
p  0.0001 vs. NYHA class I–II; †p  0.0001 vs. mitral regurgitation 0–1.
NSVT  non-sustained ventricular tachycardia; NYHA  New York Heart
ssociation; TF-BRS  baroreflex sensitivity by the transfer function method.iscrimination. The area under the curve was 0.68 0.06 for TF-BRS and
.61  0.05 for LVEF. bvent rate was much higher than in the subjects with a
easurable BRS (36% vs. 19%, p  0.002). In the patients
n whom the measurement could not be performed for other
auses, the event rate was 17%. Accordingly, a new prog-
ostic index (TF risk index) was derived in the following
anner: a patient was considered at high risk if TF-BRS
as depressed (i.e., 3.1 ms/mm Hg) or if failure to
easure TF-BRS was due to high ectopic activity; con-
ersely, he/she was considered at low risk if TF-BRS was
ore preserved (i.e., 3.1 ms/mm Hg). Survival analysis
as then carried out on this new dataset comprising 309
ubjects (97% of the original sample).
redictive value of the TF risk index. Univariable Cox
nalysis results and figures of predictive accuracy for the TF
isk index are given in the far-right column of Table 3.
orresponding Kaplan-Meier survival curves are shown in
igure 4. The prognostic performance of the TF index was
uite similar to that found for TF-BRS, except that sensi-
ivity increased at the expense of specificity.
Among the clinical and functional parameters listed in
able 1, gender, NYHA functional class, resting SAP,
igure 3. Kaplan-Meier survival curves according to dichotomized of
aroreflex sensitivity by the transfer function method (TF-BRS) (n 228).
stimated survival probabilities (95% confidence interval) at 12, 24, and 36
onths are: 0.97 (0.94 to 1.00), 0.92 (0.87 to 0.97), 0.87 (0.80 to 0.93),
espectively, for TF-BRS 3.1 ms/mm Hg; and 0.88 (0.82 to 0.95), 0.73
0.63 to 0.82), 0.65 (0.55 to 0.76), respectively, for TF-BRS 3.1 ms/
m Hg.
able 3. Results From Cox Analysis and Figures of Predictive
ccuracy for Dichotomized TF-BRS (3.1 ms/mm Hg vs.
3.1 ms/mm Hg) and for the TF Index
TF-BRS
(n  228)
TF Risk Index
(n  309)
ald chi-square 13.1 18.7
value 0.0003 0.0001
azard ratio 3.2 (1.7–6.0)* 3.5 (2.0–6.2)
ensitivity† 70% 82%
pecificity† 67% 52%
PV† 31% 32%
PV† 91% 91%
Values within brackets are 95% confidence intervals; †Computations are for a
wo-year outcome event.NPV  negative predictive value; PPV  positive predictive value; TF-BRS 
aroreflex sensitivity by the transfer function method.
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October 4, 2005:1314–21 Applicability of the Transfer Function MethodVEF, mitral regurgitation, left ventricular end diastolic
nd systolic dimensions, sodium, potassium, bilirubin, cre-
tinine, blood urea nitrogen, and number of ventricular
remature contractions (VPC)/h showed a p value0.15 in
nivariable proportional hazards analysis. With these vari-
bles as adjusting factors in a multivariable Cox model, the
F risk index maintained a highly significant association
ith the outcome, with an adjusted hazard ratio of 2.5 (95%
I: 1.3 to 4.6, p  0.004). Significant covariates remaining
n the model were: mean SAP (p  0.046), bilirubin (p 
.006), potassium (p  0.0006), and number of VPCs/h (p
0.0001). There was no interaction between TF risk index
nd beta-blocker treatment (p  0.32).
ISCUSSION
imple, non-invasive, and requiring limited resources, the
F method has gained the attention of many investigators,
ncluding our group, as an ideal tool to measure the
aroreceptor-heart rate reflex in the clinical setting of
atients with deranged autonomic cardiovascular control.
herefore, to verify this reasonable expectation, in this study
e assessed the clinical applicability and relevance of the
ethod in moderate-to-severe CHF patients. We found
hat: 1) the measurability of TF-BRS was markedly affected
y the high prevalence of severe ectopic activity in the
tudied population; 2) clinical correlates were similar to
hose previously found measuring BRS by the classical
henylephrine test (10); 3) a depressed TF-BRS was asso-
iated with a worse prognosis; and 4) combining the
rognostic information derived from measured BRS with
hat related to the reasons for failed measurement, a new
isk index could be obtained in almost all studied patients,
arrying predictive information independent of that of most
igure 4. Kaplan-Meier survival curves according to the transfer function
TF)-index (n  309). Subjects at high risk are those with depressed
aroreflex sensitivity (BRS) (i.e., TF-BRS 3.1 ms/mm Hg) or having a
issing BRS due to high ectopic activity, whereas subjects at low risk are
hose with more preserved BRS (i.e., TF-BRS 3.1 ms/mm Hg).
stimated survival probabilities (95% confidence interval) at 12, 24, and 36
onths are: 0.97 (0.94 to 1.00), 0.92 (0.87 to 0.97), and 0.87 (0.80 to
.93), respectively, for low risk; and 0.87 (0.82 to 0.92), 0.71 (0.64 to 0.78),
.62 (0.54 to 0.70), respectively, for high risk.ommon clinical and functional indicators. Measurability of the TF-BRS method. In its original
ormulation (16), the TF method required the coherence
etween SAP and RR interval to be 0.5 to guarantee
eliable BRS estimates. Applying this criterion to post-
yocardial infarction and CHF patients, BRS can not be
easured in a considerable number of cases (19). It is easy
o show that low or very low coherence values represent a
natural” phenomenon in pathological subjects, because they
eflect an impaired reflex function and/or a poor signal-to-
oise ratio (17,19). Moreover, the reliability of TF estimates
epends on other factors in addition to the coherence (17).
herefore, new analysis criteria not based on the coherence
unction have been devised and evaluated (18). These
heoretical and experimental results constituted the basis of
he methodological approach followed in the present study.
Although, in the computation of TF-BRS, we did not
se any coherence constraint, 28% of the recordings could
ot be analyzed, mostly owing to high ectopic activity.
aking into account that 26% of the patients admitted to
ur Heart Failure Unit had atrial fibrillation, atrial flutter, or
n implanted pacemaker, which is another exclusion crite-
ion for BRS estimation, the actual rate of measurability of
F-BRS in our population is near 50%.
linical correlates. The TF-BRS was significantly lower
n patients with more severe symptoms and higher mitral
egurgitation, whereas a non-significant change was ob-
erved between patients with ischemic and idiopathic car-
iomyopathy and between patients with and without non-
ustained ventricular tachycardia. A poor, albeit statistically
ignificant, correlation was found with both LVEF and
DNN. These results are very similar to those previously
ound with the classical phenylephrine test to estimate BRS
10) and clearly suggest that, although the agreement
etween pharmacological and spectral measurements is poor
28,19), both techniques reflect the clinical and functional
tatus of the patients in the same manner.
rognostic value. A reduced TF-BRS was significantly
ssociated with a poor outcome. This finding confirms our
revious investigation in a cohort of CHF patients enrolled
uring the four years preceding the beginning of the present
tudy (10) and strongly supports the notion that an impaired
aroreflex plays an important role in the progression of the
isease and event occurrence, despite marked changes in
harmacological treatment. Although the two-year predic-
ive discrimination of TF-BRS, as quantified by the area
nder the ROC curve, was moderate (0.68), it was higher
han or superimposable to the other continuous variables
onsidered in the study.
An interesting finding of this study was the strong
ssociation between failure in BRS measurement due to
igh ectopic activity and the outcome, the event rate being
lmost double in non-measurable cases compared with the
est of the patients. Since the former constituted a remark-
ble portion of the study population, this result deserves
urther investigations to fully assess its clinical relevance.
oreover, a moderate correlation was found between the
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nd that observed in Holter recordings. Although this is
ikely to be due, to a great extent, to the marked differences
etween the two recording conditions (24-h versus short-
erm), we can not exclude a specific role of the paced
reathing protocol. Indeed, we found that in more than 20%
f the patients with failed measurement, ectopic activity was
bsent or markedly reduced during spontaneous breathing.
his might be related to the condition of slight mental effort
nd mild hyperventilation that occurs during voluntary
ontrol of breathing in some patients (25).
A new risk index was derived, grouping together the
atients with missing TF-BRS due to ectopic beats with
hose with depressed BRS. In this way, risk classification
ould be extended to 97% of the studied sample. This
trategy proved to be successful, because not only the risk
ndex was strongly associated with the outcome but its
redictive value was substantially maintained after adjust-
ent for all significant clinical and functional parameters.
It is noteworthy that we found the number of VPCs/h
mong the adjusting factors that entered the final multi-
ariable model, although the risk index already contained
ome information related to ectopy rate. This seems to
urther support the notion that the appearance of a high
umber of ectopic beats (mainly ventricular) during a
hort-term paced-breathing recording carries a specific clin-
cal and, perhaps, physiopathological information additive
o that achievable through Holter recording.
ssumptions and limitations of the transfer function
ethod. A few final remarks have to be made on some
ntrinsic methodological limitations of the TF-BRS
ethod. As with all other measurement techniques, this
ethod is based on a set of assumptions that represent a
reat simplification of the underlying physiological mecha-
isms. In particular, the computation of the TF between
AP and RR interval assumes an open-loop and linear link
etween the two signals and the absence of other influences
n the RR interval in addition to the baroreflex and
ncorrelated disturbances (17). Although some experimen-
al studies provide indirect support to most of these assump-
ions (20,29), it is not yet known how robust the technique
s in pathological subjects. Moreover, being restricted to the
nalysis of oscillatory components between 0.04 and 0.15
z, the TF method takes into account only a portion of the
verall cardiovascular dynamics, whose relevance in every-
ay life has not yet been fully elucidated. Hence, it would be
ensible to state that TF-BRS measurements “reflect” the
ransfer properties of the baroreflex, rather than being the
true BRS” of a given subject. Despite these limitations,
owever, it is worth emphasizing that the TF method does
ot require a pharmacological intervention to raise or lower
lood pressure and is not time-consuming in terms of data
cquisition.
onclusions. Despite its theoretical and practical appeal,
he measurability of baroreceptor-heart rate reflex in
HF patients by the TF-BRS method is markedlyffected by the presence of severe ectopic activity. This
imitation would be particularly relevant in pathophysio-
ogical investigations, because it might cause an impor-
ant selection bias in the interpretation of results. In the
linical setting, however, where the identification of
obust prognostic markers for CHF is of major concern,
e can use the information on baroreflex sensitivity (from
ubjects with a measurable TF-BRS) in combination with
he information on the reasons for failed measurement
from subjects with a non-measurable TF-BRS) to obtain
risk index. This index can be computed in almost all
atients in sinus rhythm and provides significant and
ndependent prognostic information.
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